Aav vectors for retinal and cns gene therapy
US-2017096683-A1 · Apr 6, 2017 · US
US11034732B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11034732-B2 |
| Application number | US-201916409317-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 10, 2019 |
| Priority date | May 10, 2017 |
| Publication date | Jun 15, 2021 |
| Grant date | Jun 15, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and compositions are provided that can be used to modify the assembly activating protein (AAP)-dependence of an adeno-associated virus (AAV).
Opening claim text (preview).
What is claimed is: 1. An adeno-associated virus (AAV) capsid polypeptide comprising an amino acid sequence having at least 99% sequence identity to the amino acid sequence of SEQ ID NO: 3. 2. The AAV capsid polypeptide of claim 1 , having the amino acid sequence of SEQ ID NO:3. 3. The AAV capsid polypeptide of claim 1 , encoded by the nucleic acid sequence of SEQ ID NO: 4. 4. A virus particle comprising the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 5. The virus particle of claim 4 , further comprising a transgene. 6. A nucleic acid molecule comprising a nucleic acid sequence encoding the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 7. The nucleic acid molecule of claim 6 , having the nucleic acid sequence of SEQ ID NO: 4. 8. The nucleic acid molecule of claim 6 , encoding the amino acid sequence of SEQ ID NO: 3. 9. A vector comprising the nucleic acid molecule of claim 6 . 10. A host cell comprising the nucleic acid molecule of claim 6 . 11. The host cell of claim 10 , wherein the host cell is a packaging cell. 12. A packaging cell comprising a nucleic acid molecule encoding the adeno-associated virus (AAV) capsid polypeptide of claim 1 . 13. The packaging cell of claim 12 , wherein the packaging cell lacks an assembly activating protein (AAP). 14. An AAV capsid polypeptide comprising the amino acid sequence of SEQ ID NO:1 comprising amino acid substitutions K163T, A2065, K478R, L481V, V520M, T528S, L586N, A592Q, P593A, N599H, S600N, and A603V.
viral genome or elements thereof as genetic vector · CPC title
from viruses · CPC title
Viral vectors · CPC title
New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes · CPC title
Parvoviridae, e.g. feline panleukopenia virus, human parvovirus · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.